Expression profile analysis by complementary DNA microarray using a large number of clinical cases also revealed overexpression of SUV39H2 in cervical, bladder, oesophageal and prostate cancers, as well as in osteosarcomas and soft tissue sarcomas (Supplementary Table 1). The gene discussed is SUV39H2; the disease is prostate cancer.